Global Irritable Bowel Syndrome Drug Supply, Demand and Key Producers, 2023-2029
The global Irritable Bowel Syndrome Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Irritable Bowel Syndrome Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Irritable Bowel Syndrome Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Irritable Bowel Syndrome Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Irritable Bowel Syndrome Drug total market, 2018-2029, (USD Million)
Global Irritable Bowel Syndrome Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Irritable Bowel Syndrome Drug total market, key domestic companies and share, (USD Million)
Global Irritable Bowel Syndrome Drug revenue by player and market share 2018-2023, (USD Million)
Global Irritable Bowel Syndrome Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Irritable Bowel Syndrome Drug total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Irritable Bowel Syndrome Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals and Allergan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Irritable Bowel Syndrome Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Irritable Bowel Syndrome Drug Market, By Region:
1. How big is the global Irritable Bowel Syndrome Drug market?
2. What is the demand of the global Irritable Bowel Syndrome Drug market?
3. What is the year over year growth of the global Irritable Bowel Syndrome Drug market?
4. What is the total value of the global Irritable Bowel Syndrome Drug market?
5. Who are the major players in the global Irritable Bowel Syndrome Drug market?
This report studies the global Irritable Bowel Syndrome Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Irritable Bowel Syndrome Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Irritable Bowel Syndrome Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Irritable Bowel Syndrome Drug total market, 2018-2029, (USD Million)
Global Irritable Bowel Syndrome Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Irritable Bowel Syndrome Drug total market, key domestic companies and share, (USD Million)
Global Irritable Bowel Syndrome Drug revenue by player and market share 2018-2023, (USD Million)
Global Irritable Bowel Syndrome Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Irritable Bowel Syndrome Drug total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Irritable Bowel Syndrome Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals and Allergan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Irritable Bowel Syndrome Drug market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Irritable Bowel Syndrome Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- IBS-D Drugs
- IBS-C Drugs
- Others
- Women
- Men
- Ironwood Pharmaceuticals
- Bausch Health
- Takeda
- Sebela Pharmaceuticals
- Allergan
1. How big is the global Irritable Bowel Syndrome Drug market?
2. What is the demand of the global Irritable Bowel Syndrome Drug market?
3. What is the year over year growth of the global Irritable Bowel Syndrome Drug market?
4. What is the total value of the global Irritable Bowel Syndrome Drug market?
5. Who are the major players in the global Irritable Bowel Syndrome Drug market?
1 SUPPLY SUMMARY
1.1 Irritable Bowel Syndrome Drug Introduction
1.2 World Irritable Bowel Syndrome Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Irritable Bowel Syndrome Drug Total Market by Region (by Headquarter Location)
1.3.1 World Irritable Bowel Syndrome Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.3 China Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.4 Europe Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.5 Japan Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.6 South Korea Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.7 ASEAN Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.8 India Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Irritable Bowel Syndrome Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Irritable Bowel Syndrome Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.2 World Irritable Bowel Syndrome Drug Consumption Value by Region
2.2.1 World Irritable Bowel Syndrome Drug Consumption Value by Region (2018-2023)
2.2.2 World Irritable Bowel Syndrome Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.4 China Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.5 Europe Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.6 Japan Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.7 South Korea Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.8 ASEAN Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.9 India Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
3 WORLD IRRITABLE BOWEL SYNDROME DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Irritable Bowel Syndrome Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Irritable Bowel Syndrome Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Irritable Bowel Syndrome Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Irritable Bowel Syndrome Drug in 2022
3.3 Irritable Bowel Syndrome Drug Company Evaluation Quadrant
3.4 Irritable Bowel Syndrome Drug Market: Overall Company Footprint Analysis
3.4.1 Irritable Bowel Syndrome Drug Market: Region Footprint
3.4.2 Irritable Bowel Syndrome Drug Market: Company Product Type Footprint
3.4.3 Irritable Bowel Syndrome Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Irritable Bowel Syndrome Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Irritable Bowel Syndrome Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Irritable Bowel Syndrome Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Irritable Bowel Syndrome Drug Consumption Value Comparison
4.2.1 United States VS China: Irritable Bowel Syndrome Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Irritable Bowel Syndrome Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Irritable Bowel Syndrome Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Irritable Bowel Syndrome Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023)
4.4 China Based Companies Irritable Bowel Syndrome Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Irritable Bowel Syndrome Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023)
4.5 Rest of World Based Irritable Bowel Syndrome Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Irritable Bowel Syndrome Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Irritable Bowel Syndrome Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 IBS-D Drugs
5.2.2 IBS-C Drugs
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Irritable Bowel Syndrome Drug Market Size by Type (2018-2023)
5.3.2 World Irritable Bowel Syndrome Drug Market Size by Type (2024-2029)
5.3.3 World Irritable Bowel Syndrome Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Irritable Bowel Syndrome Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Women
6.2.2 Men
6.3 Market Segment by Application
6.3.1 World Irritable Bowel Syndrome Drug Market Size by Application (2018-2023)
6.3.2 World Irritable Bowel Syndrome Drug Market Size by Application (2024-2029)
6.3.3 World Irritable Bowel Syndrome Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Ironwood Pharmaceuticals
7.1.1 Ironwood Pharmaceuticals Details
7.1.2 Ironwood Pharmaceuticals Major Business
7.1.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Product and Services
7.1.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Ironwood Pharmaceuticals Recent Developments/Updates
7.1.6 Ironwood Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Bausch Health
7.2.1 Bausch Health Details
7.2.2 Bausch Health Major Business
7.2.3 Bausch Health Irritable Bowel Syndrome Drug Product and Services
7.2.4 Bausch Health Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bausch Health Recent Developments/Updates
7.2.6 Bausch Health Competitive Strengths & Weaknesses
7.3 Takeda
7.3.1 Takeda Details
7.3.2 Takeda Major Business
7.3.3 Takeda Irritable Bowel Syndrome Drug Product and Services
7.3.4 Takeda Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Takeda Recent Developments/Updates
7.3.6 Takeda Competitive Strengths & Weaknesses
7.4 Sebela Pharmaceuticals
7.4.1 Sebela Pharmaceuticals Details
7.4.2 Sebela Pharmaceuticals Major Business
7.4.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Product and Services
7.4.4 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sebela Pharmaceuticals Recent Developments/Updates
7.4.6 Sebela Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Allergan
7.5.1 Allergan Details
7.5.2 Allergan Major Business
7.5.3 Allergan Irritable Bowel Syndrome Drug Product and Services
7.5.4 Allergan Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Allergan Recent Developments/Updates
7.5.6 Allergan Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Irritable Bowel Syndrome Drug Industry Chain
8.2 Irritable Bowel Syndrome Drug Upstream Analysis
8.3 Irritable Bowel Syndrome Drug Midstream Analysis
8.4 Irritable Bowel Syndrome Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Irritable Bowel Syndrome Drug Introduction
1.2 World Irritable Bowel Syndrome Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Irritable Bowel Syndrome Drug Total Market by Region (by Headquarter Location)
1.3.1 World Irritable Bowel Syndrome Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.3 China Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.4 Europe Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.5 Japan Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.6 South Korea Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.7 ASEAN Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.3.8 India Irritable Bowel Syndrome Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Irritable Bowel Syndrome Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Irritable Bowel Syndrome Drug Major Market Trends
2 DEMAND SUMMARY
2.1 World Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.2 World Irritable Bowel Syndrome Drug Consumption Value by Region
2.2.1 World Irritable Bowel Syndrome Drug Consumption Value by Region (2018-2023)
2.2.2 World Irritable Bowel Syndrome Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.4 China Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.5 Europe Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.6 Japan Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.7 South Korea Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.8 ASEAN Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
2.9 India Irritable Bowel Syndrome Drug Consumption Value (2018-2029)
3 WORLD IRRITABLE BOWEL SYNDROME DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Irritable Bowel Syndrome Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Irritable Bowel Syndrome Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Irritable Bowel Syndrome Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Irritable Bowel Syndrome Drug in 2022
3.3 Irritable Bowel Syndrome Drug Company Evaluation Quadrant
3.4 Irritable Bowel Syndrome Drug Market: Overall Company Footprint Analysis
3.4.1 Irritable Bowel Syndrome Drug Market: Region Footprint
3.4.2 Irritable Bowel Syndrome Drug Market: Company Product Type Footprint
3.4.3 Irritable Bowel Syndrome Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Irritable Bowel Syndrome Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Irritable Bowel Syndrome Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Irritable Bowel Syndrome Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Irritable Bowel Syndrome Drug Consumption Value Comparison
4.2.1 United States VS China: Irritable Bowel Syndrome Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Irritable Bowel Syndrome Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Irritable Bowel Syndrome Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Irritable Bowel Syndrome Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023)
4.4 China Based Companies Irritable Bowel Syndrome Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Irritable Bowel Syndrome Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023)
4.5 Rest of World Based Irritable Bowel Syndrome Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Irritable Bowel Syndrome Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Irritable Bowel Syndrome Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 IBS-D Drugs
5.2.2 IBS-C Drugs
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Irritable Bowel Syndrome Drug Market Size by Type (2018-2023)
5.3.2 World Irritable Bowel Syndrome Drug Market Size by Type (2024-2029)
5.3.3 World Irritable Bowel Syndrome Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Irritable Bowel Syndrome Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Women
6.2.2 Men
6.3 Market Segment by Application
6.3.1 World Irritable Bowel Syndrome Drug Market Size by Application (2018-2023)
6.3.2 World Irritable Bowel Syndrome Drug Market Size by Application (2024-2029)
6.3.3 World Irritable Bowel Syndrome Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Ironwood Pharmaceuticals
7.1.1 Ironwood Pharmaceuticals Details
7.1.2 Ironwood Pharmaceuticals Major Business
7.1.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Product and Services
7.1.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Ironwood Pharmaceuticals Recent Developments/Updates
7.1.6 Ironwood Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Bausch Health
7.2.1 Bausch Health Details
7.2.2 Bausch Health Major Business
7.2.3 Bausch Health Irritable Bowel Syndrome Drug Product and Services
7.2.4 Bausch Health Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Bausch Health Recent Developments/Updates
7.2.6 Bausch Health Competitive Strengths & Weaknesses
7.3 Takeda
7.3.1 Takeda Details
7.3.2 Takeda Major Business
7.3.3 Takeda Irritable Bowel Syndrome Drug Product and Services
7.3.4 Takeda Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Takeda Recent Developments/Updates
7.3.6 Takeda Competitive Strengths & Weaknesses
7.4 Sebela Pharmaceuticals
7.4.1 Sebela Pharmaceuticals Details
7.4.2 Sebela Pharmaceuticals Major Business
7.4.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Product and Services
7.4.4 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Sebela Pharmaceuticals Recent Developments/Updates
7.4.6 Sebela Pharmaceuticals Competitive Strengths & Weaknesses
7.5 Allergan
7.5.1 Allergan Details
7.5.2 Allergan Major Business
7.5.3 Allergan Irritable Bowel Syndrome Drug Product and Services
7.5.4 Allergan Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Allergan Recent Developments/Updates
7.5.6 Allergan Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Irritable Bowel Syndrome Drug Industry Chain
8.2 Irritable Bowel Syndrome Drug Upstream Analysis
8.3 Irritable Bowel Syndrome Drug Midstream Analysis
8.4 Irritable Bowel Syndrome Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Irritable Bowel Syndrome Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Irritable Bowel Syndrome Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Irritable Bowel Syndrome Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Irritable Bowel Syndrome Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Irritable Bowel Syndrome Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Irritable Bowel Syndrome Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Irritable Bowel Syndrome Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Irritable Bowel Syndrome Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Irritable Bowel Syndrome Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Irritable Bowel Syndrome Drug Players in 2022
Table 12. World Irritable Bowel Syndrome Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Irritable Bowel Syndrome Drug Company Evaluation Quadrant
Table 14. Head Office of Key Irritable Bowel Syndrome Drug Player
Table 15. Irritable Bowel Syndrome Drug Market: Company Product Type Footprint
Table 16. Irritable Bowel Syndrome Drug Market: Company Product Application Footprint
Table 17. Irritable Bowel Syndrome Drug Mergers & Acquisitions Activity
Table 18. United States VS China Irritable Bowel Syndrome Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Irritable Bowel Syndrome Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Irritable Bowel Syndrome Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Irritable Bowel Syndrome Drug Revenue Market Share (2018-2023)
Table 23. China Based Irritable Bowel Syndrome Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Irritable Bowel Syndrome Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Irritable Bowel Syndrome Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Irritable Bowel Syndrome Drug Revenue Market Share (2018-2023)
Table 29. World Irritable Bowel Syndrome Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Irritable Bowel Syndrome Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Irritable Bowel Syndrome Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Irritable Bowel Syndrome Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Irritable Bowel Syndrome Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Irritable Bowel Syndrome Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Ironwood Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. Ironwood Pharmaceuticals Major Business
Table 37. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Product and Services
Table 38. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Ironwood Pharmaceuticals Recent Developments/Updates
Table 40. Ironwood Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. Bausch Health Basic Information, Area Served and Competitors
Table 42. Bausch Health Major Business
Table 43. Bausch Health Irritable Bowel Syndrome Drug Product and Services
Table 44. Bausch Health Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bausch Health Recent Developments/Updates
Table 46. Bausch Health Competitive Strengths & Weaknesses
Table 47. Takeda Basic Information, Area Served and Competitors
Table 48. Takeda Major Business
Table 49. Takeda Irritable Bowel Syndrome Drug Product and Services
Table 50. Takeda Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Takeda Recent Developments/Updates
Table 52. Takeda Competitive Strengths & Weaknesses
Table 53. Sebela Pharmaceuticals Basic Information, Area Served and Competitors
Table 54. Sebela Pharmaceuticals Major Business
Table 55. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Product and Services
Table 56. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sebela Pharmaceuticals Recent Developments/Updates
Table 58. Allergan Basic Information, Area Served and Competitors
Table 59. Allergan Major Business
Table 60. Allergan Irritable Bowel Syndrome Drug Product and Services
Table 61. Allergan Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Irritable Bowel Syndrome Drug Upstream (Raw Materials)
Table 63. Irritable Bowel Syndrome Drug Typical Customers
Table 1. World Irritable Bowel Syndrome Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Irritable Bowel Syndrome Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Irritable Bowel Syndrome Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Irritable Bowel Syndrome Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Irritable Bowel Syndrome Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Irritable Bowel Syndrome Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Irritable Bowel Syndrome Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Irritable Bowel Syndrome Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Irritable Bowel Syndrome Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Irritable Bowel Syndrome Drug Players in 2022
Table 12. World Irritable Bowel Syndrome Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Irritable Bowel Syndrome Drug Company Evaluation Quadrant
Table 14. Head Office of Key Irritable Bowel Syndrome Drug Player
Table 15. Irritable Bowel Syndrome Drug Market: Company Product Type Footprint
Table 16. Irritable Bowel Syndrome Drug Market: Company Product Application Footprint
Table 17. Irritable Bowel Syndrome Drug Mergers & Acquisitions Activity
Table 18. United States VS China Irritable Bowel Syndrome Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Irritable Bowel Syndrome Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Irritable Bowel Syndrome Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Irritable Bowel Syndrome Drug Revenue Market Share (2018-2023)
Table 23. China Based Irritable Bowel Syndrome Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Irritable Bowel Syndrome Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Irritable Bowel Syndrome Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Irritable Bowel Syndrome Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Irritable Bowel Syndrome Drug Revenue Market Share (2018-2023)
Table 29. World Irritable Bowel Syndrome Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Irritable Bowel Syndrome Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Irritable Bowel Syndrome Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Irritable Bowel Syndrome Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Irritable Bowel Syndrome Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Irritable Bowel Syndrome Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. Ironwood Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. Ironwood Pharmaceuticals Major Business
Table 37. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Product and Services
Table 38. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Ironwood Pharmaceuticals Recent Developments/Updates
Table 40. Ironwood Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. Bausch Health Basic Information, Area Served and Competitors
Table 42. Bausch Health Major Business
Table 43. Bausch Health Irritable Bowel Syndrome Drug Product and Services
Table 44. Bausch Health Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Bausch Health Recent Developments/Updates
Table 46. Bausch Health Competitive Strengths & Weaknesses
Table 47. Takeda Basic Information, Area Served and Competitors
Table 48. Takeda Major Business
Table 49. Takeda Irritable Bowel Syndrome Drug Product and Services
Table 50. Takeda Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Takeda Recent Developments/Updates
Table 52. Takeda Competitive Strengths & Weaknesses
Table 53. Sebela Pharmaceuticals Basic Information, Area Served and Competitors
Table 54. Sebela Pharmaceuticals Major Business
Table 55. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Product and Services
Table 56. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Sebela Pharmaceuticals Recent Developments/Updates
Table 58. Allergan Basic Information, Area Served and Competitors
Table 59. Allergan Major Business
Table 60. Allergan Irritable Bowel Syndrome Drug Product and Services
Table 61. Allergan Irritable Bowel Syndrome Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 62. Global Key Players of Irritable Bowel Syndrome Drug Upstream (Raw Materials)
Table 63. Irritable Bowel Syndrome Drug Typical Customers
LIST OF FIGURES
Figure 1. Irritable Bowel Syndrome Drug Picture
Figure 2. World Irritable Bowel Syndrome Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Irritable Bowel Syndrome Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Irritable Bowel Syndrome Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Irritable Bowel Syndrome Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 13. Irritable Bowel Syndrome Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Irritable Bowel Syndrome Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Irritable Bowel Syndrome Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Irritable Bowel Syndrome Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Irritable Bowel Syndrome Drug Markets in 2022
Figure 27. United States VS China: Irritable Bowel Syndrome Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Irritable Bowel Syndrome Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Irritable Bowel Syndrome Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Irritable Bowel Syndrome Drug Market Size Market Share by Type in 2022
Figure 31. IBS-D Drugs
Figure 32. IBS-C Drugs
Figure 33. Others
Figure 34. World Irritable Bowel Syndrome Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Irritable Bowel Syndrome Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Irritable Bowel Syndrome Drug Market Size Market Share by Application in 2022
Figure 37. Women
Figure 38. Men
Figure 39. Irritable Bowel Syndrome Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Irritable Bowel Syndrome Drug Picture
Figure 2. World Irritable Bowel Syndrome Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Irritable Bowel Syndrome Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Irritable Bowel Syndrome Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Irritable Bowel Syndrome Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Irritable Bowel Syndrome Drug Revenue (2018-2029) & (USD Million)
Figure 13. Irritable Bowel Syndrome Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Irritable Bowel Syndrome Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Irritable Bowel Syndrome Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Irritable Bowel Syndrome Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Irritable Bowel Syndrome Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Irritable Bowel Syndrome Drug Markets in 2022
Figure 27. United States VS China: Irritable Bowel Syndrome Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Irritable Bowel Syndrome Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Irritable Bowel Syndrome Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Irritable Bowel Syndrome Drug Market Size Market Share by Type in 2022
Figure 31. IBS-D Drugs
Figure 32. IBS-C Drugs
Figure 33. Others
Figure 34. World Irritable Bowel Syndrome Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Irritable Bowel Syndrome Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Irritable Bowel Syndrome Drug Market Size Market Share by Application in 2022
Figure 37. Women
Figure 38. Men
Figure 39. Irritable Bowel Syndrome Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
